Stansberry Venture Technology: review of price, cadence & strategy

Editor Dave Lashmet looks for little-known small-cap companies developing new drugs and technologies, aiming for venture-capital-like opportunities in public markets. The page lists about 15-25 positions and publication on the fourth Tuesday of each month. Stansberry's product page does not list the subscription price.

Want to see what you get before paying? Read recent issues in the official archive.

Facts checked on 2026-10-17 at the official page. Prices can change; confirm before you subscribe. We do not publish ratings or performance claims.